Filing Details

Accession Number:
0001209191-21-051524
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-16 08:33:22
Reporting Period:
2021-08-13
Accepted Time:
2021-08-16 08:33:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
944809 Opko Health Inc. OPK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
898860 Al Et Md Phillip Frost Opko Health, Inc.
4400 Biscayne Blvd.
Miami FL 33137
Ceo & Chairman Yes Yes Yes No
1380896 Trust Investments Gamma Frost 4400 Biscayne Blvd.
Miami FL 33137
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-13 4,518 $3.68 192,976,212 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 13,682 $3.68 192,989,894 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 5,108 $3.69 192,995,002 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 2,292 $3.69 192,997,294 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 53,873 $3.69 193,051,167 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 500 $3.70 193,051,667 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 17,988 $3.70 193,069,655 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 700 $3.71 193,070,355 No 4 P Indirect See Footnote
Common Stock Acquisiton 2021-08-13 1,339 $3.71 193,071,694 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,068,951 Direct
Common Stock 30,127,177 Indirect See Footnote
Footnotes
  1. The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.